About Science Partnerships News Careers Contact Partnerships Open-Innovation Labratory In the coming months, HiFiBiO plans to launch its Open Innovation Laboratory – a collaborative space with biotechnology, biopharmaceutical, and life science start-ups to accelerate innovative technology and solutions for unmet medical needs. HiFiBiO Therapeutics is located within the heart of Cambridge, MA. Collaborators will have access to HiFiBiO Therapeutics’ research tools and capabilities, and the opportunity to tap into a wide network to advance scientific endeavors. HiFiBiO is currently accepting inquiries for the Open Innovation Laboratory. Please contact us to learn more. Contact us for more information Welcoming open-innovation collaborations with high-potential biotechnology, biopharmaceutical, and life science start-ups WE ARE LOOKING FOR Novel ideas for immune modulation Explorative and breakthrough modalities centered around biologics New technologies and applications for single-cell platform Innovative approaches for identifying biomarkers and stratifying patients Next generation biological systems for evaluation of biotherapeutics WE ARE OFFERING Collaborative funding opportunities Access to HiFiBiO research capabilities and expertise, including antibody discovery and development and single-cell analysis Stimulating scientific environment and supportive culture Global network Contact us today to learn more about our open-innovation strategies and partnerships Full Name Company Name Email Country Select your Country United States France China Afghanistan Albania Algeria American Samoa Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Colombia Comoros Congo, Democratic Republic of the Congo, Republic of the Costa Rica Côte d'Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Faroe Islands Fiji Finland France French Polynesia Gabon Gambia Georgia Germany Ghana Greece Greenland Grenada Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati North Korea South Korea Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria Northern Mariana Islands Norway Oman Pakistan Palau Palestine, State of Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Romania Russia Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Sudan, South Suriname Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands, British Virgin Islands, U.S. Yemen Zambia Zimbabwe Area of Interest Make a Selection Antibody Discovery Biomarker Discovery Licensing Opportunity Novel Target Discovery Open Innovation Lab Job Opportunities Your message By submitting this form you agree to our Privacy Policy. About Science Partnerships News Careers Contact © HiFiBiO Therapeutics, 2021. All Rights Reserved. Privacy Policy Manage cookie settings